ABHD12 antibody (AA 110-250)
Quick Overview for ABHD12 antibody (AA 110-250) (ABIN7265355)
Target
See all ABHD12 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 110-250
-
Purpose
- ABHD12 Rabbit pAb
-
Sequence
- YFIDLKKPQD QGLNHTCNYY LQPEEDVTIG VWHTVPAVWW KNAQGKDQMW YEDALASSHP IILYLHGNAG TRGGDHRVEL YKVLSSLGYH VVTFDYRGWG DSVGTPSERG MTYDALHVFD WIKARSGDNP VYIWGHSLGT G
-
Cross-Reactivity
- Human, Rat
-
Characteristics
- Polyclonal Antibodies
-
Purification
- Affinity purification
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 110-250 of human ABHD12 (NP_056415.1).
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB,1:500 - 1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- ABHD12 (Abhydrolase Domain Containing 12 (ABHD12))
-
Alternative Name
- ABHD12
-
Background
- This gene encodes an enzyme that catalyzes the hydrolysis of 2-arachidonoyl glycerol (2-AG), the main endocannabinoid lipid transmitter that acts on cannabinoid receptors, CB1 and CB2. The endocannabinoid system is involved in a wide range of physiological processes, including neurotransmission, mood, appetite, pain appreciation, addiction behavior, and inflammation. Mutations in this gene are associated with the neurodegenerative disease, PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract), resulting from an inborn error of endocannabinoid metabolism. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene.[provided by RefSeq, Jan 2011],ABHD12A,BEM46L2,C20orf22,PHARC,dJ965G21.2,ABHD12,ABHD12
-
Gene ID
- 26090
-
UniProt
- Q8N2K0
Target
-